当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2018年第7期
编号:13292274
医生培训对伴有房颤的急性缺血性卒中患者抗凝治疗的影 响(2)
http://www.100md.com 2018年7月1日 《健康必读·下旬刊》 2018年第7期
     Zhao YJ, Lin L, Zhou HJ, et al. Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation. Int J Cardiol, 2016, 220:794-801.

    饒明俐. 中国脑血管病防治指南[J]. 中风与神经疾病杂志, 2006, 23(1):5-6.

    January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2014, 64(21):e1-76.

    Kirchhof P, Ammentorp B, Darius H, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events-European Registry in Atrial Fibrillation (PREFER in AF). Europace, 2014, 16(1):6-14.

    O’Brien EC, Holmes DN, Ansell JE, et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J, 2014, 167(4):601-609., 百拇医药(唐铁钰 段作伟 刘一辉)
上一页1 2